시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
승모판 질환 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년)
Mitral Valve Disease Market - Global Mitral Valve Disease Industry Analysis, Size, Share, Growth, Trends and Forecast 2023-2030 -
상품코드 : 1490839
리서치사 : Fairfield Market Research
발행일 : 2024년 05월
페이지 정보 : 영문 193 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,995 ￦ 7,254,000
Unprintable PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.
US $ 8,495 ￦ 12,338,000
Unprintable PDF & Excel (Multi User License upto 5 users) help
PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.
US $ 10,600 ￦ 15,395,000
Printable PDF & Excel (Enterprise License above 5 users) help
PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

승모판 질환 시장 규모는 현재의 28억 달러에서 2030년까지 51억 2,000만 달러로 급증할 것으로 보이고 있습니다. 시장 매출은 2023-2030년 CAGR 9%의 고성장이 예측됩니다.

승모판 질환 시장은 선천적 이상과 감염으로 인한 승모판 질환의 유병률 증가로 인해 크게 확대되고 있습니다. 선천적 문제는 승모판막의 구조를 변화시켜 협착 및 역류와 같은 상태를 유발할 수 있습니다. 전 세계 인구의 고령화도 승모판 질환의 유병률 증가에 중요한 역할을 하고 있으며, 이로 인해 새로운 치료법에 대한 수요가 증가하고 있습니다. 승모판막 심장판막 및 관련 약물의 개발 및 승인에 대한 엄격한 규제에도 불구하고 의료 기술의 발전은 승모판 질환의 관리를 계속 강화하고 있습니다.

승모판 질환은 가장 흔한 심장 판막 질환 중 하나이며, 전 세계에서 수백만 명이 앓고 있습니다. 세계보건기구(WHO)에 따르면 전 세계에서 약 2,600만 명이 승모판 질환을 앓고 있습니다. 이 질환의 유병률은 연령에 따라 증가하며, 세계 인구의 고령화에 따라 효과적인 치료법에 대한 수요가 증가하고 있습니다. 또한 당뇨병과 비만과 같은 위험 요인은 승모판막 기능 부전의 발생률을 증가시켜 시장을 더욱 견인하고 있습니다.

세계의 승모판 질환 시장에 대해 조사했으며, 시장의 개요와 치료 유형별, 적응증별, 병기별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 경쟁 동향 등을 제공하고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 세계의 승모판 질환 시장 전망, 2018-2030년

제4장 북미의 승모판 질환 시장 전망, 2018-2030년

제5장 유럽의 승모판 질환 시장 전망, 2018-2030년

제6장 아시아태평양의 승모판 질환 시장 전망, 2018-2030년

제7장 라틴아메리카 승모판 질환 시장 전망, 2018-2030년

제8장 중동 및 아프리카의 승모판 질환 시장 전망, 2018-2030년

제9장 경쟁 구도

제10장 부록

KSA
영문 목차

영문목차

Market Overview

Mitral valve disease market size is set to surge from its current valuation of US$2.8 Bn to US$5.12 Bn by 2030. The market revenue is projected to experience a strong CAGR of 9% between 2023 and 2030.

The mitral valve disease market is experiencing significant expansion, driven by the increasing prevalence of mitral valve issues due to congenital abnormalities and infections. Congenital problems can alter the structure of the mitral valve, leading to conditions such as stenosis or regurgitation. The ageing global population also plays a critical role in the rising prevalence of mitral valve disease, thereby increasing the demand for new treatments. Despite stringent regulatory controls on the development and approval of mitral heart valves and related drugs, advancements in medical technology continue to enhance the management of mitral valve diseases.

Key Market Drivers

1. Growing Prevalence of Mitral Valve Disease: Mitral valve disease is among the most common heart valve conditions, affecting millions worldwide. According to the World Health Organization (WHO), approximately 26 million people globally suffer from mitral valve disease. The prevalence of this condition increases with age, and as the global population continues to age, the demand for effective treatments rises. Additionally, risk factors like diabetes and obesity further drive the market by increasing the incidence of mitral valve dysfunction.

2. Advancements in Technology: Innovations in medical technology and new treatment approaches have significantly improved the management of mitral valve disorders. Devices like the MitraClip, which offer a minimally invasive option for mitral valve repair, reduce mitral regurgitation and alleviate symptoms for patients who are not candidates for traditional surgery. Such technological advancements are driving the adoption of advanced treatments in the mitral valve disease market.

3. Increasing Adoption of Minimally Invasive Techniques: The demand for minimally invasive techniques for treating mitral valve disorders is growing. The development of devices like the Intrepid transcatheter mitral valve replacement (TMVR) system, which utilizes a minimally invasive transfemoral access approach, exemplifies this trend. These innovations are expected to propel market growth as they provide effective alternatives to traditional surgical procedures.

Market Challenges

1. High Costs Associated with Mitral Valve Replacement: The high cost of mitral valve replacement and repair surgeries poses a significant barrier to market growth. The cost of these procedures can vary based on factors such as disease severity, the type of procedure, and the healthcare facility. The financial burden associated with these surgeries can limit their accessibility, especially in lower-income regions.

2. Potentially Unfavorable Health Consequences: Regulatory restrictions imposed by governing bodies on the use, approval, and development of mitral heart valves and medications also hinder market growth. Strict guidelines must be followed during the production of mitral valve repair, replacement, and cardiac resynchronization devices to ensure their safety and quality. These regulations can slow down the development and commercialization of new treatments.

Emerging Trends and Opportunities

1. Growing Screening and Awareness Initiatives: Enhanced awareness campaigns, early diagnosis programs, and increased patient screening efforts are positively impacting the market. Early diagnosis by healthcare professionals improves the likelihood of successful treatments and enhances patient outcomes. Increased awareness leads to higher demand for advanced treatments, contributing to market growth.

2. Increasing Demand for Targeted Therapies and Personalized Medicine: Personalized medicine approaches, which tailor treatments based on individual patient characteristics and disease severity, have the potential to improve treatment outcomes and patient satisfaction. The integration of genetic testing and biomarker analysis into treatment decisions can optimize therapy approaches and drive market growth.

3. Expanding Presence of Key Companies: Collaborations between companies and healthcare organizations, along with exploring underserved regions for expansion, offer significant growth opportunities. Companies can increase market penetration by expanding product portfolios and distribution networks, creating a more competitive market landscape.

Regional Market Leaders

North America: North America is expected to hold the largest market share for mitral valve disease during the forecast period. The region's advanced healthcare system, increased consumer awareness, and high prevalence of mitral valve diseases contribute to this dominance. The rapid adoption of transcatheter mitral valve repair and replacement technology, along with significant improvements in minimally invasive procedures, is driving market growth in North America.

Asia-Pacific: The Asia-Pacific region is projected to experience the highest growth rate, driven by a large population base and rising purchasing power in countries like China and India. The booming pharmaceutical industry in these countries further supports this trend, making Asia-Pacific a key player in the global mitral valve disease market.

Europe: Europe also shows significant growth potential, driven by a well-established healthcare infrastructure and increased funding for the research and development of advanced treatments. European nations are focusing on developing cutting-edge medical technologies and personalized medical strategies, contributing to market growth.

In conclusion, the global mitral valve disease market is set for substantial growth, driven by the rising prevalence of mitral valve problems, technological advancements, and the increasing adoption of minimally invasive techniques. Addressing regulatory challenges and potential health risks will be crucial for sustaining growth and maximizing the market's potential.

Competitive Analysis

Global Mitral Valve Disease Treatment Market is Segmented as:

By Treatment Type

By Indication

By Stage

By End User

By Geographic Coverage:

Table of Contents

1. Executive Summary

2. Market Overview

3. Global Mitral Valve Disease Market Outlook, 2018 - 2030

4. North America Mitral Valve Disease Market Outlook, 2018 - 2030

5. Europe Mitral Valve Disease Market Outlook, 2018 - 2030

6. Asia Pacific Mitral Valve Disease Market Outlook, 2018 - 2030

7. Latin America Mitral Valve Disease Market Outlook, 2018 - 2030

8. Middle East & Africa Mitral Valve Disease Market Outlook, 2018 - 2030

9. Competitive Landscape

10. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기